A recent report published by Infinium Global Research on near infrared imaging market provides in-depth analysis of segments and sub-segments in the global as well as regional near infrared imaging market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional near infrared imaging market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global near infrared imaging market.
The near infrared imaging market refers to the global industry focused on the development, production, and application of imaging systems that utilize near-infrared light (typically 700–900 nm wavelength) to visualize tissues, organs, and physiological functions in real time. Over the past year, the emergence of NIR-II window imaging (1000–1700 nm), using carbon-nanotube and Ag₂S quantum-dot probes, has enabled deep tissue visualization with micron-level resolution at millimeter depths, surpassing traditional NIR-I capabilities. Hyperspectral and multispectral NIR systems, now miniaturized into handheld and smartphone-compatible units, offer richer datasets and faster analysis for clinical and industrial use. Leading players of the market include KARL STORZ SE & Co. KG., Hamamatsu Photonics K.K., Shimadzu Corporation, Medtronic, and others. Companies in the near infrared imaging market are implementing strategies such as forming research collaborations with academic institutions, investing in AI-integrated imaging platforms, expanding product portfolios through innovation in NIR-II technologies, and targeting emerging markets through affordable, compact devices.
The increasing number of surgical procedures globally is significantly fostering growth in the Near-Infrared (NIR) Imaging market. As the volume of surgeries, particularly in oncology, reconstructive, gastrointestinal, and cardiovascular fields, continues rising, demand surges for NIR-guided visualization to improve outcomes in minimally invasive and tumor-resection procedures. Moreover, cosmetic and microsurgeries leveraging NIR for precise perfusion and vascular imaging are expanding use cases. Additionally, the growing adoption of minimally invasive procedures is propelling the growth of the near-infrared (NIR) Imaging market. These procedures require enhanced visualization tools to ensure precision, reduce complications, and minimize tissue damage, making NIR imaging an ideal solution. As healthcare systems prioritize patient-centered care, the reliance on NIR imaging for minimally invasive interventions continues to accelerate market growth. However, high initial cost and operating expenses are significantly hindering the growth of the Near-Infrared (NIR) Imaging market. The procurement of advanced NIR imaging systems, along with specialized components such as fluorophores and detectors, demands substantial capital investment, making them unaffordable for smaller healthcare facilities, especially in developing regions. Furthermore, integration with AI and machine learning is expected to create lucrative opportunities in the Near-Infrared (NIR) Imaging market in the coming years. These technologies will enable automated image interpretation, anomaly detection, and enhanced visualization, reduce human error, and improve diagnostic precision. AI-driven analytics may process complex imaging data in real time, aiding surgeons in decision-making during critical procedures.
The segment of the reagent dominated the market and attained the largest revenue share of around 57.5%. Reagents hold several benefits over conventional visible light dyes, such as high sensitivity and specific detection in biological systems. They belong to the type Indocyanine Green (ICG) and other reagents. The segment of the reagent will grow immensely over the forecast period due to the benefits of ICG. Indocyanine green allows real-time angiographic imaging during vascular or brain tumor surgery. It is also being used increasingly in spine surgery. Hence, the growing applications of ICG and its advantages are a few of the most important growth promoters for the segment.
The preclinical imaging segment will dominate the market throughout the forecast period with a market share of 35.5%. Near-infrared (NIR) reagents are an essential ingredient in preclinical imaging research on the research of diseases such as cancer, inflammation, and infection. Sophisticated NIR reagents, like those of PerkinElmer Inc. COX-2 probe, provide improved tissue penetration and fluorescence, facilitating enhanced clinical development of oncology therapeutics. Intracerebral oxygen monitoring during cardiovascular interventions will also be needed to further improve surgical outcomes, generating still more need for NIR imaging.
The segment of hospitals and clinics accounts for the highest revenue share of over 45.2% and will expand the most among all segments in the forecast period. This is owing to rising cancer patient admissions in clinics and hospitals, and the presence of well-established healthcare facilities in developed nations. Near-infrared technology is heavily used in hospitals and clinics for the detection of bedsores, thereby avoiding surgical mistakes. Laparoscopic devices that feature near-infrared sensors prevent surgeons from accidentally severing blood vessels. Use of the devices is a part of minimizing surgery mistakes and lowering hospital stay time and medical expenditures for patients. Furthermore, greater patient demand for minimally invasive and efficient surgery will drive demand for near-infrared products as well.
North America currently dominates the global near-infrared (NIR) imaging market with a share of 41.1% due to several unique factors. The region’s advanced healthcare infrastructure, high healthcare expenditure, and broad insurance penetration support widespread adoption of cutting-edge imaging technologies. A large chronic and aging patient population, combined with a strong clinical emphasis on early detection, minimally invasive procedures, and reconstructive surgery, fuels demand for real-time, non-ionizing imaging methods. Moreover, North America benefits from robust research and development funding, including major NIH grants and active collaborations between top universities and industry leaders, accelerating innovation. As a result, the region holds a substantial share of global revenue. Furthermore, the Asia‑Pacific is expected to grow with the fastest CAGR in the near‑infrared (NIR) imaging market, attributed to several unique drivers such as soaring prevalence of chronic diseases (cancer, cardiovascular disorders), especially across China, India, Japan, and Southeast Asia, boosting demand for non‑invasive diagnostic imaging. Rapid expansion of healthcare infrastructure, rising disposable incomes, and improving affordability support greater penetration of NIR technologies. Multinational firms increasingly form strategic alliances with domestic players to tailor and distribute cost‑effective solutions.
In February 2025, Stryker completed the acquisition of Inari Medical, Inc., a company that offers innovative solutions for the removal of venous thromboembolism (VTE) clots without the use of thrombolytic drugs. The addition of Inari enhances Stryker's established position in peripheral vascular within the rapidly growing VTE market.
In November 2024, Hamamatsu Photonics K.K. completed the acquisition of BAE Systems Imaging Solutions, Inc., a subsidiary of BAE Systems, Inc., thereby enhancing the opto-semiconductor segment with advanced CMOS image sensor technologies.
In February 2025, Leica Microsystems announced the acquisition of ATTO-TEC, a specialty supplier of fluorescent dyes and reagents.
| Report Coverage | Details |
|---|---|
| Market Size in 2023 | USD 2.18 Billion |
| Market Size by 2032 | USD 3.09 Billion |
| Growth Rate from 2024 to 2032 | CAGR of 3.98% |
| Largest Market | North America |
| No. of Pages | 255 |
| Market Drivers |
|
| Market Segmentation | By Product, By Application, and By End-use |
| Regional Scope | North America, Europe, Asia Pacific, and RoW |
The report on global near infrared imaging market provides a detailed analysis of segments in the market based on Product, Application, and End-use.
· Devices
o Near-infrared Fluorescence Imaging Systems
o Near-infrared Fluorescence & Bioluminescence Imaging Systems
· Reagents
o Indocyanine Green (ICG)
o Other Reagents
· Preclinical Imaging
· Cancer Surgeries
· Gastrointestinal Surgeries
· Cardiovascular Surgeries
· Plastic / Reconstructive Surgeries
· Other Applications
· Hospitals & Clinics
· Pharmaceutical & Biotechnology Companies
· Research Laboratories
· KARL STORZ SE & Co. KG.
· Hamamatsu Photonics K.K.
· Shimadzu Corporation
· Medtronic
· Olympus Corporation
· LI-COR Biotech, LLC
· PerkinElmer
· Gowerlabs Ltd.
· Stryker
· ZEISS Group
The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the near infrared imaging market. Moreover, the study highlights current market trends and provides forecasts from 2024-2032. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.